Instructor in Pediatrics
THE OPPORTUNITY
This opportunity to join the Department of Pediatrics at the Vagelos College of Physicians and Surgeons at the rank of Instructor is an exciting one. Columbia University Irving Medical Center, one of the nation’s foremost academic health science center’s working together with one of the nation’s premier health systems, New York-Presbyterian Hospital.
KEY RESPONSIBILITIES
Columbia University College of Physicians and Surgeons and New York-Presbyterian Hospital are recruiting for a full-time academic pediatric faculty member in the Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation at the Instructor level on the non-tenure track. This position will be focused on laboratory-based research related to identification of new, more effective therapies for malignant brain tumors. The successful candidate will have the opportunity to collaborate with the outstanding clinical and research faculty within the division and at the Columbia University Irving Medical Center and the NCI-designated Herbert Irving Comprehensive Cancer Center (HICCC), the Mailman School of Public Health.
Founded in 1959, The Division of Pediatric Hematology, Oncology, and Stem Cell Transplant at Columbia Children’s Health, New York-Presbyterian Morgan Stanley Children’s Hospital (MSCH) is one of the oldest and most comprehensive centers in the country focused on treating children with cancer and blood disorders. MSCH has 202 inpatient pediatric beds, including a 54-bed Pediatric Intensive Care Unit and 10 operating rooms. Our division is currently composed of 3 sections (Hematology, Oncology and Stem Cell Transplantation) with 21 full-time faculty, 4 research RN/NP’s, 8 clinical research associates, and 3 regulatory specialists and includes an ACGME-accredited Fellowship Program and a FACT-accredited stem cell transplant program. The division is one of 21 institutions to serve as a core sire of the Children’s Oncology Group Pediatric Early Phase Clinical Trials Network (PEP-CTN). It is also a member of the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium.
Research Responsibilities:
Laboratory-based research efforts will focus on development of novel therapies for malignant brain tumors, including the identification of active drugs and drug combinations, and testing novel drug delivery methods, including convection enhanced delivery. Research projects will be conducted under the mentorship of senior investigators at CUIMC and HICCC. It is expected that 80% effort will be devoted to laboratory-based research activities.
Clinical Responsibilities:
Clinical responsibilities will include serving as attending physician on the inpatient oncology service and providing outpatient care to children, adolescents and young adults with oncologic conditions, focused on those with neuro-oncologic diagnoses. . In addition, the successful candidate will be expected to attend and participate in clinical oncology meetings, as well as divisional and departmental clinical conferences. It is expected that 20% effort will be devoted to clinical activities.
- Must have an MD, DO or PhD degree and an active NYS Medical License.
- Must be Board certified/eligible in Pediatric Hematology/Oncology or an equivalent board certification with experience in the care of pediatric stem cell transplant patients.
- Laboratory experience related to the field of neuro-oncology, as well as the use of high-throughput screening, single cell RNA sequencing, and mouse models to screen for active therapies and novel drug delivery methodologies.
- Consistently strong interpersonal skills and the ability to build and sustain effective working relationships with professionals in other disciplines.
- The ability to create a high-energy, results-oriented work environment that encourages colleagues and staff to value each other?s contributions and the ability to share and celebrate success with colleagues and staff.
Find Your Best Opportunity
Tell them AcademicJobs.com sent you!
